Top Small Cap Negative News Movers Premarket: RETO: -65% Pricing of $15 Million Registered Direct Offering LGVN: -52% Announces Topline Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel SNYR: -50% Delisting Notice DLXY: -48% Momentum Mover NAMI: -33% Momentum Mover TGL: -30% Momentum Mover
Top Small Cap Negative News Movers Premarket: RETO: -65% Pricing of $15 Million Registered Direct Offering LGVN: -52% Announces Topline Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel SNYR: -50% Delisting Notice DLXY: -48% Momentum Mover NAMI: -33% Momentum Mover TGL: -30% Momentum Mover